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Abstract 
Purpose: This study was carried out to determine the relationship of daily dietary fructose intake 
with body composition and some biochemical parameters in individuals with diabetes. 
Method and material: A total of 156 individuals with diabetes, 53 men and 103 women, between 
the ages of 30 and 65 (?̅?=51±8.59 years old) participated in the study. Research data was obtained 
through face-to-face interviews conducted by the researcher using a questionnaire, which included 
general information, dietary habits, daily food consumption record. 
Results: The fructose intake of the men was 13.2±12.09 g/day and that of the women was 
13.6±11.10 g/day (p>0.05). The ratios of the daily dietary energy intake from fructose were 
7.4±5.56% and 7.4±5.34% in men and women, respectively. It was determined that the individuals 
consuming the highest levels of fructose (Q4) had higher BMI, waist circumference and average 
visceral fat, serum VLDL-C, HbA1c levels and lower serum HDL-C levels than the individuals 
consuming the lowest levels of fructose (Q1). It was observed that Q4 obtain higher levels of 
energy, carbohydrates and fat than Q1 (p<0.05). Prevalence of obesity was found to be the lowest 
(59.0%) in the group intake the lowest levels of fructose and the highest (64.1%) in the group 
intake the highest levels of fructose (p>0.05). 
Conclusion: Further studies are needed to develop more specific suggestions regarding fructose 
intake and to better understand the relationship between fructose intakes, body composition and 
biochemical parameters in individuals with type 2 diabetes. 
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1. Introduction 
 
Diabetes results from deficiency in the production of insulin in the body or the 
development of insensitivity of the cells to insulin (Chiavaroli et al., 2014) . Considering global 
estimates, experts expect the number of people with diabetes will reach 48.3 million worldwide in 
2050 (Sheehy et al., 2009). This increase in diabetes is attributed to the decrease in physical 
activity and the increase in obesity (Chiavaroli et al., 2014). Intake of some nutrients such as 
fructose as well as excess energy intake is also thought to cause the development of diabetes. In 
the past, fructose intake was provided by fruits and honey etc which is contain high fructose, and 
daily intake was between 16 and 20 g. However, daily fructose intake has increased up to 85-100 g 
in the last 30 years due to the addition of sugar (sucrose, high fructose corn syrup (HFCS), 
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honey, molasses and other syrups) to carbonated beverages, fruit juices, canned fruits, bakery 
products and jams (Basciano et al., 2005; Bray, 2008). Commercially HFCS contain either 42% or 
55% fructose, and 55% type is used more (55% fructose, 42-44% glucose, 1-3% polysaccharide) 
(Forshee et al., 2007). Commercially HFCS is a stronger sweetener than sucrose and it is 
preferred by food manufacturers because it is cheaper, does not crystallize quickly and has a 
flavour-enhancing effect (Neilson, 2007). One of the causes of obesity and metabolic syndrome is 
the excessive consumption of sugar added products particularly those containing fructose 
(Schulze et al., 2004; Hossain et al., 2007). Recent studies indicate that the increase in fructose 
intake runs in parallel with the increase in the number of people with obesity and type 2 diabetes 
(Johnson et al., 2007; Goran et al., 2013). In addition, excessive fructose intake is reported to be 
associated with diseases such as hypertension, hyperlipidemia, non-alcoholic steatohepatitis and 
gout (Wang et al., 2012; White, 2013). 
The metabolism of fructose operates differently than that of glucose (Gaby, 2005). 
Fructose is transported into the intestinal cells via GLUT-5 which is a specific fructose 
transporter. Being Na-independent, this process does not require energy. Fructose absorbed in 
the intestinal cells is then released into the bloodstream via the GLUT2 transporters in the 
enterocyte basolateral membrane. A portion of the fructose in the enterocytes is converted into 
lactate while another portion is converted into glucose via triose phosphate. The main target 
organ of the fructose in the bloodstream is the liver (Feinman & Fine, 2013). This step is the 
basic difference between the metabolisms of glucose and fructose. Phosphofructokinase, which is 
a regulatory enzyme, takes part when glucose is metabolized. Fructose, on the other hand, 
bypasses this regulatory step and passes directly through the glycolytic pathway step. Since 
fructose metabolism cannot be regulated at this stage, it causes the production of a large amount 
of glycolysis product which leads to an increase in the synthesis of fatty acids. Fructose is 
phosphorylated without entering the glycolytic pathway and unlike glucokinase, fructokinase 
cannot be regulated by insulin. Increased synthesis of fatty acids may increase the fatty acids and 
adipose in the circulation. This, depending on the development of fatty acids in tissues other than 
the adipose tissue, may lead to lipotoxicity which reduces the insulin sensitivity of cells (Neilson, 
2007). Insulin secretion of the pancreatic cells affected by fructose-induced lipotoxicity may 
decrease (Stephan et al., 2010). It is also stated that fructose cannot stimulate leptin secretion 
sufficiently and cannot suppress ghrelin secretion which in turn increases appetite and decreases 
satiety (Johnson et al., 2007). Therefore, excessive fructose intake can lead to excessive energy 
intake and hence weight gain (Stephan et al., 2010). 
Although the effects of fructose on individuals with diabetics are not very clear, diabetic 
patients have the impression that it can be a therapeutic tool in their diet because its glycemic 
index is low and it does not require insulin in its metabolism (Crapo et al., 1981; Mayes, 1993). In 
addition, it has also been reported that fructose has a positive effect in that it increases energy 
expenditure in obese individuals with or without diabetes (Tappyet al., 1986; Simonson et al., 
1988). However, fructose is given a separate place in diabetes guidelines due to its effect on lipids. 
It is stated in ADA guidelines that when starch and sucrose are replaced by fructose in a diet, it 
generates a lower glycemic response and while doing that, fructose shows no adverse effect on 
lipids (Bantle et al., 2008). However, it has also been reported in a study that fructose has a 
detrimental effect on insulin resistance when it replaces starch in a 5-week long diet in which 
15% of the daily energy is taken/intake from fructose (Hallfrisch et al., 1983). 
For these reasons, this study was planned and carried out in order to determine the 
relationship between daily fructose intake, body composition and some biochemical parameters 
in individuals with type 2 diabetes. 
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2. Method and Materials 
 
2.1. Participants 
 
This study was carried out at Gazi University Hospital in the department of 
Endocrinology and Metabolism. The participants were randomly selected from patients with type 
2 diabetes who applied to the clinic between January 2014-January 2015. Patients (103 females, 53 
males) between the ages of 30 and 65 years old. Participants signed a voluntary participation form 
which adhered to Declaration of Helsinki protocols. Pregnant women, lactating women, those 
with hormonal disease, type-1 diabetes and oncological diseases were excluded from the study.  
Committee approval from Gazi University Ethics Commission was obtained for this 
study. 
2.2. Dietary assement  
 
Research data were collected through face-to-face interviews conducted by the researcher 
using a questionnaire developed by the researchers. The frequency of the participants’ food 
consumption was recorded in order to determine the amount of fructose they consume daily. 
The Fructose Frequency Form includes items containing nutrients such as energizing soft drinks, 
sodas and fruit juices, and some fructose-rich fruits and vegetables. The food consumption of the 
participants was determined by making a record of food consumption for 3 days (1 weekend day, 
2 weekdays). The amount and content of all the foods consumed by the individuals was written 
down on the food consumption record form. Gram quantities of the foods listed in the food 
consumption records were calculated using the "Food and Nutrition Photo Catalogue: Size and 
Quantity" (Rakıcıoğlu et al., 2012). The Nutrition Information Systems program was used for 
daily energy and nutrients provided by the quantity of food consumed (Bebis, 2004). 
2.3. Anthropometric measurements 
 
The participants’ body weight, body fat mass, fat free mass, water mass and body fat 
percentage were measured using a Tanita BC 545N portable bioelectrical impedance device 
(BIA). Anthropometric measurements were taken by trained dieticians and with participants 
wearing light clothes and no shoes. A portable scale was used to measure body weight to the 
nearest half-kilogram. Height was measured to the nearest 0.1 cm with a wall-mounted 
stadiometer. Waist circumference (WC) was measured above the iliac crest and below the lowest 
rib margin at minimum respiration. Hip circumference (HC) was measured at the widest part of 
the hip at the level of the greater trochanter to the nearest half-centimeter. The waist and hip 
circumferences were measured with a tape (Pekcan, 2008). 
Body mass index (BMI) was calculated by dividing body weight by the square meter of 
the height (Body weight (kg)/height (m)2). The evaluation of body mass index was based on the 
classification of the World Health Organization (WHO, 2000). 
2.4. Biochemical Parameters 
 
Biochemical parameters routinely checked at the hospital (fasting plasma glucose, HbA1c, 
total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein 
cholesterol (LDL-C), triglycerides (TG)) were evaluated based on the patient files. Fasting plasma 
lipids and concentrations of TG, HDL-C and total TC were analysed and LDL-C concentrations 
were calculated. Early morning venous blood samples were obtained from each participant for 
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biochemical screening tests, following a twelve-hour overnight fast. Professional staff performed 
venipuncture by using vacutainers to obtain 15 mL of whole blood. Blood was centrifuged for 
plasma separation at government hospitals where the actual biochemical analyses were 
performed.  
2.5. Statistical Analysis 
 
Statistical analyses were performed using SPSS version 16.0 software package. Descriptive 
analyses were made with mean ± standard deviation and median±IQR (interquartile range from 
widths). Frequencies and percentages were used for nominal variables. The Chi-square test was 
carried out for between group difference, and the Mann-Whitney U test was used for pairwise 
comparisons. Relationships between variables were analyzed using the Spearman's rank 
correlation coefficient, classification (hazard) situations were grouped according to odds ratios 
obtained from logistic regression, fructose intake was grouped as quarters (Q1, Q2, Q3, Q4) and 
between group difference was determined by the ANOVA and Tukey test. Significance was 
evaluated at p<0.05 level. 
3. Results 
This study was conducted on a total of 156 individuals with type 2 diabetes, 53 men and 
103 women, between the ages of 30 and 65. The average age of the male subjects who 
participated in the study was 50.36±8.27 years while that of the female subjects was 51.5±8.59 
years. The mean duration of diagnosis of diabetes was 5.6±5.64 years for the men and 6.1±6.89 
for the women. 90.4% of the individuals received pharmacological treatment for blood glucose 
regulation. 34.4% of these individuals received oral antidiabetics, 22% received insulin and 53.8% 
received both insulin and antidiabetics (data was not shown). 
The daily fructose intake values of the men and women were 13.2±12.09 g and 
13.6±11.10 g, respectively (p>0.05). It was determined that the ratios of the daily dietary energy 
from fructose were 7.4±5.56% and 7.4±5.34% in men and women, respectively. It was 
determined that the amount of sucrose (11.7±16.11 g) the male participants received from their 
daily diet was lower than that (12.4±13.95 g) of the female participants (p>0.05). The ratios of 
the total energy received from sucrose in the daily diet were 2.2±2.82% and 3.2±3.49% in men 
and women, respectively (Table 1). 
Table 1. Daily fructose and sucrose intake according to gender of the participants 
 Male (n:53) Female (n:103)   
 M±IQR M±IQR t p 
Fructose (g) 13.2±12.09 13.6±11.10 0.353 0.724 
Fructose (TE%) 7.4±5.56 7.4±5.34 -0.326 0.745 
Fructose (CHO%) 3.2±2.41 3.2±2.40 0.435 0.664 
Sucrose (g) 11.7±16.11 12.4±13.95 -0.775 0.440 
Sucrose (TE%)  2.2±2.82 3.2±3.49 -1.324 0.188 
Sucrose (CHO%) 5.9±6.08 7.2±7.40 -1.369 0.173 
 
It was determined that the individuals consuming the highest levels of fructose (Q4) had 
higher BMI, waist circumference and the average visceral fat, VLDL-C, HbA1c levels and lower 
HDL-C levels than individuals consuming the lowest levels of fructose (Q1) (p>0.05). It was 
detected that individuals of Q4 obtained higher levels of energy, carbohydrates and protein than 
those individuals of Q1 (p<0.05, Table 2). 
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Table 2. Anthropometric measurements, biochemical parameters and macro nutrient intakes of 
the individuals based on their fructose intake groups 
 
Q1a Q2b Q3c Q4d 
  
 
?̅?±SS ?̅?±SS ?̅?±SS ?̅?±SS F p 
Tukey 
test 
BMI (kg/m2) 32.0±6.09 31.8±5.56 30.1±4.76 32.9±5.82 1.706 0.168 
- 
Waist 
circumference 
(cm) 
97.7±9.21 98.0±8.11 94.4±13.30 99.0±16.76 0.787 0.503 
- 
Hip 
circumference 
(cm) 
110.0±11.19 109.9±8.56 105.7±12.68 111.3±13.87 1.704 0.169 
- 
Visceral fat 10.5±3.13 11.4±4.72 10.6±6.54 11.9±2.66 0.834 0.477 - 
Fasting plasma 
glucose (mg/dL) 
149.2±61.47 158.1±64,12 144.2±53.43   149.8±52.73 0.386 0.763 
- 
TG (mg/dL) 199.3±187.68 182.8±76,53 162.8±74.52 187.1±114.84 0.599 0.616 - 
TC (mg/dL) 200.3±38.18 204.2±38,72 188.9±46.35 191.9±33.76 1.263 0.289 - 
LDL-C (mg/dL) 123.8±32.46 126.8±35,15 111.7±34.88 113.3±30.29 1.997 0.117 - 
VLDL-C 
(mg/dL) 
29.8±10.28 35.4±12.39 31.7±12.03 34.6±12.76 1.862 0.138 
- 
HDL-C (mg/dL) 46.6±10.36 43.1±10.14 46.4±12.27 45.5±7.76 0.946 0.420 - 
HbA1c (%) 7.2±1.71 7.5±1.56 7.3±1.73 7.5±1.72 0.281 0.839 - 
Energy (kcal/day) 1709.6±408.69 1652.2±354.87 1806.4±389.80 1990.7±505.58 4.899 0.003* 
 
(a-d) 
(b-d) 
Carbohydrates 
(g/day) 
187.8±71.48 166.1±48.58 197.9±48.28 228.1±74.52 6.744 0.000* 
(a-d)         
(b-d) 
Protein (g/day) 59.2±16.64 66.1±18.95 68.5±22.25 72.00±18.94 3.046 0.031* (a-d) 
Fat (g/day) 79.0±20.74 78.3±24.32 80.0±27.04 84.32±29.66 0.434 0.729 - 
Cholesterol 
(mg/day) 
226.5±119.71 234.2±125.21 255.0±146.18 307.61±220.72 2.083 0.105 
- 
*p<0,05, Q1: 1. Quartile, Q2: 2. Quartile Q3: 3. Quartile Q4: 4. Quartile  TG= triglyceride, TC=total cholesterol, LDL-
C=low density lipoprotein cholesterol, VLDL-C=very low density lipoprotein cholesterol, HDL-C= high density lipoprotein 
cholesterol 
Fructose intake of overweight individuals is 14.74±8.06 g while that of individuals with 
normal weight is 13.33±8.03 g; therefore, the difference is not statistically significant (p>0.05) 
(Table 3). 
Table 3. Fructose consumption of individuals depending on BMI classification 
   
  
Normal 
weight 
Overweight  Obese 
    
?̅?±SS ?̅?±SS ?̅?±SS F p 
Fructose (g) 13.3±8.03 14.3±7.67 14.7±8.06 0.19 0.830 
Fructose (TE%) 9.3±6.49 8.1±4.32 7.4±3.81 1.16 0.318 
Fructose (CHO%) 3.5±1.89 3.4±1.88 3.2±1.74 0.26 0.772 
 
Prevalence of obesity is 59.0% in the group with the lowest daily fructose intake while 
64.1% in the group with the highest daily fructose intake (Table 4). 
 
Arslan, S., & Sanlier, N. (2016). Relationship between daily dietary fructose intake, body composition and biochemical 
parameters patients with type 2 diabetes. Journal of Human Sciences, 13(2), 2642-2655. 
doi:10.14687/jhs.v13i2.3737 
 
 
2647 
Table 4. The distribution of BMI and biochemical parameters compared to reference values 
based on the fructose intake of the groups 
 Variables  
 
Q1 Q2 Q3 Q4 
  
 % % % % X2 p 
BMI (kg/m2) 
Normal weight 7.7 7.7 7.9 5.1 
1.78 0.94 Overweight 33.3 33.3 42.1 30.8 
Obese 59.0 59.0 50.0 64.1 
TC (mg/dL) 
<200 56.4 51.3 64.1 69.2 
3.11 0.38 
≥200 43.6 48.7 35.9 30.8 
LDL-C (mg/dL) 
<130 61.5 61.5 76.9 76.9 
4.33 0.23 
≥130 38.5 38.5 23.1 23.1 
HDL-C (mg/dL) 
<30 7.7 12.8 5.1 2.6 
3.42 0.34 
≥30 92.3 87.2 94.9 97.4 
TG (mg/dL) 
<150 44.7 33.3 53.8 38.5 
3.73 0.29 
≥150 55.3 66.7 46.2 61.5 
Fasting plasma glucose (mg/dL) >140 100.0 100.0 100.0 100.0 - - 
Q1: 1. Quartile, Q2: 2. Quartile Q3: 3. Quartile Q4: 4.Quartile 
It was determined that fructose intake was not significantly correlated with any 
parameters (Table 5).  
Table 5. The correlation between the fructose consumption of the individuals and 
anthropometric measurements and biochemical parameters (r) 
  Fructose (g) Fructose (CHO%) Fructose (TE%) 
  r p r p r p 
Body weight (kg) 0.022 0.790 -0.148 0.065 -0.123 0.128 
BMI (kg/m2) 0.069 0.396 -0.125 0.122 -0.045 0.582 
Waist circumference (cm) 0.028 0.728 -0.091 0.256 -0.030 0.713 
Hip circumference  (cm) 0.047 0.561 -0.096 0.233 -0.015 0.857 
Waist/hip ratio -0.043 0.598 -0.045 0.579 -0.048 0.548 
Body water (%) 0.040 0,621 0.063 0.431 0.036 0.658 
Muscle Mass (kg) -0.023 0.778 -0.089 0.267 -0.111 0.166 
Body fat (%) 0.119 0.139 -0.021 0.792 0.072 0.374 
Visceral fat 0.073 0.368 -0.055 0.496 0.006 0.940 
TG (mg/dL) -0.006 0.944 -0.023 0.777 -0.011 0.890 
TC (mg/dL) -0.079 0.326 -0.046 0.566 -0.071 0.377 
LDL-C (mg/dL) -0.129 0.110 -0.048 0.552 -0.099 0.221 
VLDL-C (mg/dL) 0.117 0.145 0.083 0.301 0.114 0.158 
HDL-C  (mg/dL) 0.006 0.942 -0.041 0.607 0.008 0.920 
 
No statistically significant difference was found between the group consuming high levels 
of fructose and the group consuming low levels of fructose, in terms of obesity (p>0.05) (Table 
6).  
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Table 6. The relationship between fructose intake and risk of obesity  
 
BMI <30 kg/m2 BMI ≥ 30 kg/m2 Total M Confidence Interval 
Q1 32 46 78 
0.949 0.502-1.793 Q2 33 45 78 
Total 65 91 156 
Q1: 1. Quartile, Q2:2. Quartile 
4. Discussion 
With the commercial production of HFCS in the 1970s, fructose intake also increased 
significantly from 0 kg per capita up to 29 kg annually. The fructose intake from natural sources, 
on the other hand, has remained stable. Fructose intake in American society was classified as 
moderate (0-50 g/day), high (50-100 g/day) and very high (100-150 g/day) by a meta-analysis. It 
was reported that moderate intake of fructose has potential benefits for glycemic control while 
high and very high intake of fructose may lead to risks of dysglycemia and dyslipidemia (Livesey 
& Taylor, 2008). A study conducted on healthy individuals determined that individuals consume 
about 42.3±22.73 g fructose received from dietary products, that men consume significantly 
more fructose than women and that the fructose intake of 33.3% of the individuals is ≥50 g/day 
(Koseler, 2011). In a study conducted with young people with type 1 diabetes, the total fructose 
intake was found to be 34.6 g/day (Couch et al., 2013). In another study, the daily fructose intake 
was determined to be 72.8 g/day (Vos et al., 2008)  and in the other one is 27.9±15.7 g (Lamb et 
al., 2015). In this study, the daily fructose intake of men was found to be 13.2±12.09 g and that of 
women 13.6±11.10 g (Table 1). In addition, in this study daily fructose intake mostly comes from 
natural resources, and the daily fructose intake of the individuals can be classified as low, because 
the participants in this study try to consume less sugar or sugar added foods, sodas and sugar 
sweetened soft drinks due to their diabetic conditions. Given the fact that high dietary fructose 
consumption in particular is a result of the addition of HFCS into foods, it is only natural that the 
amount of fructose the participants in this study receive from their daily diet is low. 
The ratios of fructose received from dietary energy and carbohydrates matter as much as 
its daily intake. A study conducted on young adults determined that 10-12% of the fructose 
consumed in the daily diet is received from the total energy (Park &Yetley 1993). Another study 
conducted on individuals with type 1 diabetes reported that 7.9% of the fructose consumed in 
the daily diet is received from the total energy (Couch et al., 2013) while another study reported 
12% (Vos et al., 2008). In NHANES (1999-2004) study, energy received from fructose and 
carbohydrates were found to be 18% and 41% (Marriott, 2009). This study determined that the 
ratios of the daily dietary energy received from fructose were 7.4±5.56 % and 7.4±5.34% in men 
and women, respectively (Table 1). Given the fact that energy received from fructose should be 
less than 10%, it can be asserted that these amounts are within acceptable limits. However, 
considering the latest recommendation of the WHO, which state that dietary sugar should 
account for no more than 5% of daily calories consumed, it can be argued that the participants 
should reduce their daily intake of sugar further (WHO, 2015). The ratios of the daily fructose 
received from the total carbohydrate were 3.2±2.41% and 3.2±2.40% in men and women, 
respectively (Table 1). A study conducted on individuals with type 2 diabetes indicated that oral 
intake of low amounts of fructose increased glycogen synthesis and reduced the glycemic 
response (Petersen et al., 2001). 
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Sucrose is also an important sweetener today and an important source of fructose. A 
study on healthy individuals determined that they received 50.6±33.21 g sucrose from their daily 
diet, 8.8% of the total energy from sucrose and 19.8% from carbohydrate. Another study 
conducted on individuals with type 1 diabetes reported that the daily amount of sucrose received 
from dietary intake was 48.8±24.3 g (Lamb et al,. 2015). This study determined that the amount 
of sucrose (11.7±16.11 g) the male participants received from their daily diet was lower than that 
(12.4±13.95 g) of the female participants (p>0.05) (Table 1). The ratios of the total energy 
intaken from sucrose in the daily diet were 2.2±2.82% and 3.2±3.49% in men and women, 
respectively. This may be because although these individuals have diabetes, they use sugar in 
coffee and tea, and consume, though in small amounts, sugar-containing foods such as dairy 
desserts, honey, and jam. 
Long-term consumption of foods and drinks with high fructose corn syrup leads to an 
increase in body weight (Schulze et al., 2004). It is argued that consumption of pure fructose or a 
fructose-rich diet suppresses the secretion of insulin and the production of leptin, which in turn 
causes weight gain (Havel, 2005). When a nutrition program in which 13% of the energy was 
received from beverages sweetened with fructose or from beverages sweetened with 50% 
glucose+50% fructose was applied to healthy young men for 3 weeks, waist/hip ratio was 
reported to increase; however, the same effect was not observed when glucose-sweetened 
beverages were consumed (Aeberli et al., 2011). It was reported that fructose intake led to an 
increase in visceral adipose tissue while glucose led to an increase in subcutaneous adipose tissue 
(Stanhope & Havel, 2008). Similarly, a study on healthy individuals determined that the group 
consisting of obese individuals had the highest daily fructose intake (Koseler, 2011). This study 
determined that the individuals consuming the highest levels of fructose (Q4) had higher BMI, 
waist circumference and visceral fat average than the individuals consuming the lowest levels of 
fructose (Q1). However, the difference between the two groups was not statistically significant 
(p>0.05). In this study, the fructose intake of the overweight individuals was 14.7±8.06 g and the 
levels did not show a statistically significant difference from that (13.3±8.03 g) of the individuals 
with normal BMI (Table 3). A study on individuals with diabetes failed to detect a significant 
association between fructose intake and BMI and the effect of daily dietary intake of fructose 
exceeding 50 g showed no statistically significant contribution to the risk of being overweight 
(Couch et al., 2013). It was detected that the individuals consuming the highest levels of fructose 
(Q4) obtained higher levels of energy, carbohydrates and protein than the individuals consuming 
the lowest levels of fructose (Q1) (p<0.05) (Table 2). Excessive fructose intake is thought to 
provide a positive energy balance and increase the body weight (Stanhope, 2012). Due to the fact 
that fructose does not stimulate insulin and leptin secretion, it is presumed that it may affect food 
intake and energy expenditure in the long term (Stanhope, 2012). However, studies on the effect 
of high fructose intake on body weight are mostly experimental studies carried out on rats, hence, 
case-control studies on this subject are insufficient. In this study, risk analysis calculation was 
made to determine the relationship between obesity and fructose intake. However, there was no 
statistically significant difference in terms of obesity between the groups consuming the highest 
and lowest levels of fructose (p>0.05, Table 6). This might be due to the fact that the daily 
dietary fructose intake of the participants was not high.  
When 25% of the energy is intaken from HFCS, fructose or glucose, no development of 
insulin resistance has not been observed (Stanhope et al., 2011). This effect could not be found in 
this study perhaps because the participants were young and individuals of normal weight. A meta-
analysis on fructose intake indicates that <90 g/day is the safe amount and that this dose reduces 
HbA1c concentration and has a beneficial effect (Livesey & Taylor 2008). In another study, 50 g 
of each glucose, sucrose and fructose was administered to each of the 9 healthy individuals, 10 
individuals with impaired glucose tolerance and 12 individuals with type 2 diabetes. It was 
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reported in the study that fructose intake caused lower insulin response, serum glucose level and 
glycosuria compared to glucose and sucrose intake (Crapo et al., 1980). Diabetic patients were 
administered fructose instead of other carbohydrates in a different study (Cozma et al., 2012). It 
was observed that glycemic control was positively affected (HbA1c reduction) without insulin 
being affected. This positive effect is believed to be due to the fact that fructose has a low 
glycemic index or that fructose intake in low doses upregulates the glucokinase enzyme which 
shows a catalytic effect. In a 10-week long diet in which 25% of the energy is received from 
fructose, de novo lipogenesis (DNL) speeds up in the liver of overweight and obese adults, but 
the same effect was not observed with glucose intake (Cozma et al., 2012; Stanhope et al., 2009).  
While the consumption of fructose-sweetened beverages reduced glucose tolerance and 
insulin sensitivity of obese individuals, this effect was not observed with the consumption of 
glucose-sweetened beverages (Stanhope, 2012). In another study, plasma TG, TC and LDL-C 
levels were determined to be higher in young individuals with type 1 diabetes consuming ≥1 cup 
of sugar-sweetened beverage (Bartsov et al., 2011). Fructose and glucose metabolisms are 
different from each other. Through de novo lipogenesis, fructose can develop insulin resistance 
as a direct source of lipid in the liver (Stanhope, 2012). The fact that fructose is quite lipogenic, 
stimulates the TG synthesis and increases fat accumulation in the liver through an increase in 
diacylglycerol and acyl coenzyme A (Stanhope & Havel, 2008). Compared to isocaloric glucose, 
administration of fructose has been observed to lead more to an increase in postprandial 
hypertriglyceridaemia and apolipoprotein B levels (Stanhope & Havel 2008; Swarbrick et al., 
2008).  In a study in which healthy individuals were administered a single dose of 50 g/day of 
fructose, fructose was observed to have a statistically significant association with an increase in 
TC, LDL-C and HDL-C levels, while was observed to have no significant effect on triglyceride 
levels (Jameel et al., 2014). The fact that the metabolism of fructose is different from that of 
glucose causes these effects. Unlike glucose, entry of the fructose into cells is not insulin-
dependent and due to the lack (of rate-limiting enzymes in the metabolism of the fructose, fatty 
acid biosynthesis increases. In another study, it has been determined that fructose and glucose 
may lead to the development of type 2 diabetes (Meyer et al., 2000). In this study, it was 
determined that the individuals consuming the highest levels of fructose (Q4) had higher VLDL-
C, HbA1c levels and lower HDL-C levels than individuals consuming the lowest levels of 
fructose (Q1) but the difference between the two groups was not statistically significant (p>0.05) 
(Table 2). In a study with individuals with diabetes, a statistically significant association was 
observed between fructose intake and serum TG levels while no statistically significant 
association was observed between fructose intake and TC, LDL-C and HDL-C (Couch et al., 
2013). Similarly, in this study, no statistically significant association was observed between 
fructose intake and biochemical parameters below or above the reference value. Considering the 
fact that diabetic individuals are at risk for cardiovascular diseases, their blood lipids must be kept 
under control. Although statistically significant differences were not determined due to low 
fructose intake in this study, it should be taken into account that high fructose intake may 
generate adverse effects on blood lipids. 
There are few studies on the effect of high fructose intake on body weight and the 
negative effects of fructose manifest themselves in experimental studies only when fructose 
intake is in excessive doses. Hence, this situation makes it difficult to interpret these studies as the 
amount of fructose people receive from their diets is lower than the excessive fructose intake in 
the studies. Overall, fructose was not observed to have an adverse effect on the health of the 
participants because the amount of fructose received by them was lower than 50 g. Another 
important point worth noting is that the fructose sources of the participants in this study were 
natural foods instead of HFCS-sweetened beverages; therefore, the pulp, vitamins, minerals and 
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antioxidant content of the natural foods, despite of their fructose content, may prevent from 
adverse effects. 
This study had several limitations. Due to some technical problems such as unwillingness 
of some individuals to complete the food consumption record and to take anthropometric 
measurements, some surveys had to be cancelled which limited the number of individuals 
participating in the study. Further studies that contain control groups should be carried out in 
order to provide more specific recommendations on fructose intake in diabetic individuals. 
5. Conclusion and recommendations 
Fructose intake in small amounts does not cause adverse health effects in people with 
diabetes because diabetic individuals consume fructose added foods and beverages, which are the 
primary sources of fructose, to a lesser extent. However, due to possible negative effects of 
added fructose, foods that contain high fructose corn syrup should be consumed within the limits 
specified. In addition, it is advisable to consume fructose from natural sources in such a way that 
it provides less than 10% or even 5% of the energy according to the latest recommendations. In 
case fructose is used as a sweetener, the amount used should be taken into account. Considering 
the fact that the negative effects of fructose arise mostly from the added fructose, it is important 
that not only diabetic individuals but also healthy individuals are careful about the consumption 
of such foods and individuals should even be encouraged to acquire the habit of reading food 
nutrition labels. However, some food nutrition labels do not always clearly provide information 
about the amount of fructose the food contain, which makes it difficult for people to determine 
the net amount of fructose they receive. Therefore, food nutrition labels should contain the 
information as to whether or not high fructose corn syrup was used in the production, and if so, 
the amount should be provided on the label.  
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